Schonfeld Strategic Advisors’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.84M Buy
+158,111
New +$3.17M 0.02% 678
2025
Q4
Sell
-297,851
Closed -$5.94M 2612
2025
Q3
$5.94M Buy
297,851
+79,351
+36% +$1.42M 0.04% 530
2025
Q2
$2.99M Buy
218,500
+148,711
+213% +$1.43M 0.02% 783
2025
Q1
$772K Buy
69,789
+1,689
+2% +$18K 0.01% 1391
2024
Q4
$725K Sell
68,100
-56,200
-45% -$673K ﹤0.01% 1258
2024
Q3
$1.58M Sell
124,300
-124,099
-50% -$1.84M 0.01% 992
2024
Q2
$4.17M Buy
248,399
+144,299
+139% +$2.05M 0.03% 615
2024
Q1
$1.56M Sell
104,100
-27,800
-21% -$454K 0.01% 1069
2023
Q4
$1.98M Buy
131,900
+1,700
+1% +$22.1K 0.02% 802
2023
Q3
$1.82M Buy
+130,200
New +$2.09M 0.02% 857

Other funds holding URGN